139 related articles for article (PubMed ID: 9755864)
21. Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex.
Otto H; Hanson PI; Chapman ER; Blasi J; Jahn R
Biochem Biophys Res Commun; 1995 Jul; 212(3):945-52. PubMed ID: 7626135
[TBL] [Abstract][Full Text] [Related]
22. A discontinuous SNAP-25 C-terminal coil supports exocytosis.
Chen YA; Scales SJ; Jagath JR; Scheller RH
J Biol Chem; 2001 Jul; 276(30):28503-8. PubMed ID: 11373287
[TBL] [Abstract][Full Text] [Related]
23. Truncated SNAP-25 (1-197), like botulinum neurotoxin A, can inhibit insulin secretion from HIT-T15 insulinoma cells.
Huang X; Wheeler MB; Kang YH; Sheu L; Lukacs GL; Trimble WS; Gaisano HY
Mol Endocrinol; 1998 Jul; 12(7):1060-70. PubMed ID: 9658409
[TBL] [Abstract][Full Text] [Related]
24. Identification of SNARE complex modulators that inhibit exocytosis from an alpha-helix-constrained combinatorial library.
Blanes-Mira C; Pastor MT; Valera E; Fernández-Ballester G; Merino JM; Gutierrez LM; Perez-Payá E; Ferrer-Montiel A
Biochem J; 2003 Oct; 375(Pt 1):159-66. PubMed ID: 12852787
[TBL] [Abstract][Full Text] [Related]
25. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
26. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
Foran P; Shone CC; Dolly JO
Biochemistry; 1994 Dec; 33(51):15365-74. PubMed ID: 7803399
[TBL] [Abstract][Full Text] [Related]
27. SNARE complex formation is triggered by Ca2+ and drives membrane fusion.
Chen YA; Scales SJ; Patel SM; Doung YC; Scheller RH
Cell; 1999 Apr; 97(2):165-74. PubMed ID: 10219238
[TBL] [Abstract][Full Text] [Related]
28. Functional studies in 3T3L1 cells support a role for SNARE proteins in insulin stimulation of GLUT4 translocation.
Macaulay SL; Hewish DR; Gough KH; Stoichevska V; MacPherson SF; Jagadish M; Ward CW
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):217-24. PubMed ID: 9164859
[TBL] [Abstract][Full Text] [Related]
29. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
[TBL] [Abstract][Full Text] [Related]
30. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.
Shone CC; Roberts AK
Eur J Biochem; 1994 Oct; 225(1):263-70. PubMed ID: 7925446
[TBL] [Abstract][Full Text] [Related]
31. Dual effects of botulinum neurotoxin A on the secretory stages of chromaffin cells.
Gil A; Viniegra S; Gutiérrez LM
Eur J Neurosci; 1998 Nov; 10(11):3369-78. PubMed ID: 9824450
[TBL] [Abstract][Full Text] [Related]
32. Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses.
Schiavo G; Stenbeck G; Rothman JE; Söllner TH
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):997-1001. PubMed ID: 9023371
[TBL] [Abstract][Full Text] [Related]
33. Insights into a basis for incomplete inhibition by botulinum toxin A of Ca2+-evoked exocytosis from permeabilised chromaffin cells.
Lawrence GW; Foran P; Oliver Dolly J
Toxicology; 2002 Dec; 181-182():249-53. PubMed ID: 12505320
[TBL] [Abstract][Full Text] [Related]
34. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds.
Schiavo G; Santucci A; Dasgupta BR; Mehta PP; Jontes J; Benfenati F; Wilson MC; Montecucco C
FEBS Lett; 1993 Nov; 335(1):99-103. PubMed ID: 8243676
[TBL] [Abstract][Full Text] [Related]
35. SNAP-25 with mutations in the zero layer supports normal membrane fusion kinetics.
Graham ME; Washbourne P; Wilson MC; Burgoyne RD
J Cell Sci; 2001 Dec; 114(Pt 24):4397-405. PubMed ID: 11792805
[TBL] [Abstract][Full Text] [Related]
36. Botulinum neurotoxin A and neurotoxin E cleavage products of synaptosome-associated protein of 25 kd exhibit distinct actions on pancreatic islet beta-cell Kv2.1 channel gating.
He Y; Elias CL; Huang YC; Gao X; Leung YM; Kang Y; Xie H; Chaddock JA; Tsushima RG; Gaisano HY
Pancreas; 2008 Jan; 36(1):10-7. PubMed ID: 18192874
[TBL] [Abstract][Full Text] [Related]
37. Dissociation of SNAP-25 and VAMP-2 by MgATP in permeabilized adrenal chromaffin cells.
Misonou H; Nishiki T; Sekiguchi M; Takahashi M; Kamata Y; Kozaki S; Ohara-Imaizumi M; Kumakura K
Brain Res; 1996 Oct; 737(1-2):351-5. PubMed ID: 8930391
[TBL] [Abstract][Full Text] [Related]
38. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.
Schiavo G; Rossetto O; Catsicas S; Polverino de Laureto P; DasGupta BR; Benfenati F; Montecucco C
J Biol Chem; 1993 Nov; 268(32):23784-7. PubMed ID: 8226912
[TBL] [Abstract][Full Text] [Related]
39. Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-L1 adipocytes and cleaves cellubrevin unlike type A toxin which failed to proteolyze the SNAP-23 present.
Chen F; Foran P; Shone CC; Foster KA; Melling J; Dolly JO
Biochemistry; 1997 May; 36(19):5719-28. PubMed ID: 9153412
[TBL] [Abstract][Full Text] [Related]
40. Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin.
Shone CC; Quinn CP; Wait R; Hallis B; Fooks SG; Hambleton P
Eur J Biochem; 1993 Nov; 217(3):965-71. PubMed ID: 8223654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
